These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37567894)

  • 1. Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy.
    Van Laar AD; Webb KR; Keeney MT; Van Laar VS; Zharikov A; Burton EA; Hastings TG; Glajch KE; Hirst WD; Greenamyre JT; Rocha EM
    NPJ Parkinsons Dis; 2023 Aug; 9(1):121. PubMed ID: 37567894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Neuroscience; 2012 Feb; 203():170-9. PubMed ID: 22198020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
    Rocha SM; Bantle CM; Aboellail T; Chatterjee D; Smeyne RJ; Tjalkens RB
    Neurobiol Dis; 2022 Jun; 167():105685. PubMed ID: 35257879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
    Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
    J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.
    Naughton C; O'Toole D; Kirik D; Dowd E
    Behav Brain Res; 2017 Jan; 316():160-168. PubMed ID: 27585560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
    Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
    Neurotox Res; 2022 Feb; 40(1):215-229. PubMed ID: 34817799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.
    Inden M; Kitamura Y; Takeuchi H; Yanagida T; Takata K; Kobayashi Y; Taniguchi T; Yoshimoto K; Kaneko M; Okuma Y; Taira T; Ariga H; Shimohama S
    J Neurochem; 2007 Jun; 101(6):1491-1504. PubMed ID: 17459145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly reproducible rotenone model of Parkinson's disease.
    Cannon JR; Tapias V; Na HM; Honick AS; Drolet RE; Greenamyre JT
    Neurobiol Dis; 2009 May; 34(2):279-90. PubMed ID: 19385059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
    Duffy MF; Collier TJ; Patterson JR; Kemp CJ; Luk KC; Tansey MG; Paumier KL; Kanaan NM; Fischer DL; Polinski NK; Barth OL; Howe JW; Vaikath NN; Majbour NK; El-Agnaf OMA; Sortwell CE
    J Neuroinflammation; 2018 May; 15(1):129. PubMed ID: 29716614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
    Liu Y; Sun JD; Song LK; Li J; Chu SF; Yuan YH; Chen NH
    Behav Brain Res; 2015 Nov; 294():149-61. PubMed ID: 26239001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of caloric vestibular stimulation in improvement of motor symptoms and inhibition of neuronal degeneration in rotenone model of Parkinson's disease - An experimental study.
    Thanalakshmi J; Archana R; Senthilkumar S; Shakila R; Pazhanivel N; Subhashini S
    Physiol Int; 2020 Oct; 107(3):390-405. PubMed ID: 33021954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
    Sakamula R; Yata T; Thong-Asa W
    Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
    Miyazaki I; Isooka N; Imafuku F; Sun J; Kikuoka R; Furukawa C; Asanuma M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice.
    Sharma M; Sharma N; Khairnar A
    Neurochem Res; 2023 May; 48(5):1543-1560. PubMed ID: 36571663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.
    Ma XZ; Chen LL; Qu L; Li H; Wang J; Song N; Xie JX
    Acta Pharmacol Sin; 2024 Jan; 45(1):52-65. PubMed ID: 37674043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease.
    Barbiero JK; Ramos DC; Boschen S; Bassani T; Da Cunha C; Vital MABF
    Behav Pharmacol; 2022 Dec; 33(8):513-526. PubMed ID: 36094044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethoxycurcumin, a Natural Derivative of Curcumin Abrogates Rotenone-induced Dopamine Depletion and Motor Deficits by Its Antioxidative and Anti-inflammatory Properties in Parkinsonian Rats.
    Ramkumar M; Rajasankar S; Gobi VV; Janakiraman U; Manivasagam T; Thenmozhi AJ; Essa MM; Chidambaram R; Chidambaram SB; Guillemin GJ
    Pharmacogn Mag; 2018; 14(53):9-16. PubMed ID: 29576695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats.
    Li C; Chen X; Zhang N; Song Y; Mu Y
    Neural Regen Res; 2012 Feb; 7(5):325-31. PubMed ID: 25774170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.